Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases
about
Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotypeComplement and its role in protection and pathogenesis of flavivirus infectionsA novel inhibitor of the alternative pathway of complement reverses inflammation and bone destruction in experimental arthritisUsing mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor.Structure/function studies of human decay-accelerating factorPlasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes.Identification of functional domains in kaposica, the complement control protein homolog of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8)Antagonism of the complement component C4 by flavivirus nonstructural protein NS1.Identification of the Kna/Knb polymorphism and a method for Knops genotyping.Functional analyses of complement convertases using C3 and C5-depleted sera.Complement System Part I - Molecular Mechanisms of Activation and Regulation.N-linked glycosylation of dengue virus NS1 protein modulates secretion, cell-surface expression, hexamer stability, and interactions with human complement.Hepatitis C virus NS3/4A protease inhibits complement activation by cleaving complement component 4Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney.Quantitative Modeling of the Alternative Pathway of the Complement SystemAutoantibody stabilization of the classical pathway C3 convertase leading to C3 deficiency and Neisserial sepsis: C4 nephritic factor revisited.Dissection of functional sites in herpesvirus saimiri complement control protein homolog.Identification of a complement receptor 1 peptide for inhibition of immune hemolysisRegulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode.Prevention of experimental autoimmune myasthenia gravis by rat Crry-Ig: A model agent for long-term complement inhibition in vivoMapping of functional domains in herpesvirus saimiri complement control protein homolog: complement control protein domain 2 is the smallest structural unit displaying cofactor and decay-accelerating activitiesCR1 in Alzheimer's disease.Protection of host cells by complement regulators.Complement in Kidney TransplantationCharacterization of the complement inhibitory function of rhesus rhadinovirus complement control protein (RCP).Characterization of complement receptor 1 domains for prevention of complement-mediated red cell destruction.A corresponding tyrosine residue in the C2/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertases.Decay-accelerating factor (DAF), complement receptor 1 (CR1), and factor H dissociate the complement AP C3 convertase (C3bBb) via sites on the type A domain of Bb.High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment.Expansion of the Knops blood group system and subdivision of Sl(a).No Evidence that Knops Blood Group Polymorphisms Affect Complement Receptor 1 Clustering on Erythrocytes.Displacement of C2a/Bb by CR1C1q and Mannose-Binding Lectin Interact with CR1 in the Same Region on CCP24-25 Modules.Dissecting Sites Important for Complement Regulatory Activity in Membrane Cofactor Protein (MCP; CD46)Structure-based Mapping of DAF Active Site Residues That Accelerate the Decay of C3 Convertases
P2860
Q24293121-60BDC8A0-8FA0-47B3-8103-2E7EEE3412A4Q27490236-AFB41435-8801-40F7-96DC-D5E43E43EBC8Q27645256-ABBBA2D8-D7FC-480A-928B-6B33EE852D50Q27680572-5A967CD7-671F-4BD8-AEA4-19FD2162F85BQ28139971-3F0B0AE4-9D5B-4433-8902-9DD9C07EA50CQ30425504-BE85BDDE-4AC3-4497-843E-3DC44B776A69Q30448441-245BC5CE-AA3C-4C56-AE70-BB1F571F9B1EQ33795001-70DEBF3B-9CE6-4996-BA34-C555AFFE131CQ33879882-79393CED-B6C5-4EC3-B4C6-2B4D2DFDD079Q34448109-5F182493-DA70-4D9A-BF11-14B88BC0E3CDQ34481071-0A9FD2BD-90E7-43B4-9D84-CD4FBCA66B79Q34952610-03749E07-B90E-41FB-B9C5-60F1323CF468Q35069979-D0208EFD-8407-487D-B622-5F70DC004A7FQ35741851-704F7D26-9C81-49A4-B4AF-5F809599C2F3Q35975481-C546BA6B-1724-433F-95AA-ECE7DB2A91D8Q36409764-A1A3BD79-EB88-4A59-BEAC-D263AB65B2C4Q36506856-73DEACE8-4054-4FB8-93CA-3202B6E5B7DFQ36719729-105B91E9-8BAC-477A-B9B1-7EE70FE5166BQ36906411-AE22DF4E-0D0F-4838-9F1A-1678FA3C4A02Q36947184-9A5164F5-1119-4C8A-B4BF-2A21AB745D00Q37356020-AFD243A2-83AC-40DA-BBF0-7B220703622AQ38209191-5EB006DA-6887-4A4C-BA48-C7B3C18FEED1Q38991019-6357BBF4-C9A0-4839-870D-56A64D3887FBQ39371134-9FE5BA9A-3014-4CC1-96FB-B1DEB93A9331Q40029426-460DE0EE-5062-43AF-954A-E85A03318853Q40452822-65645F4A-186E-42DD-A2FF-C803D15BF0F8Q40625728-741B80E8-41CA-46F5-B54F-C4C8B7BE8FA9Q40770484-DD0C012E-51AB-4C3A-9874-ACF242A8EF60Q42363540-2E1DFFBC-5AC8-48E3-9B3E-2CA7BE4725C4Q43918923-FA072E31-47BB-4678-9FD6-FBAC927429FFQ47144153-CD5D870A-5176-4FCD-97F8-1C208606152AQ50291913-F8E96345-0ABF-4209-8E1A-A1E547773557Q52643677-6F403A1B-1112-45F5-893B-23393DCF8021Q57936817-230BD6BC-2F95-4443-B0B1-7D64E408351BQ58210854-F84B4149-70AC-4835-B12E-E545DBBE1F20
P2860
Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Decay accelerating activity of ...... or dissociating C5 convertases
@ast
Decay accelerating activity of ...... or dissociating C5 convertases
@en
Decay accelerating activity of ...... or dissociating C5 convertases
@en-gb
Decay accelerating activity of ...... or dissociating C5 convertases
@nl
type
label
Decay accelerating activity of ...... or dissociating C5 convertases
@ast
Decay accelerating activity of ...... or dissociating C5 convertases
@en
Decay accelerating activity of ...... or dissociating C5 convertases
@en-gb
Decay accelerating activity of ...... or dissociating C5 convertases
@nl
prefLabel
Decay accelerating activity of ...... or dissociating C5 convertases
@ast
Decay accelerating activity of ...... or dissociating C5 convertases
@en
Decay accelerating activity of ...... or dissociating C5 convertases
@en-gb
Decay accelerating activity of ...... or dissociating C5 convertases
@nl
P2093
P2860
P3181
P356
P1476
Decay accelerating activity of ...... or dissociating C5 convertases
@en
P2093
B M Yurcisin
D E Hourcade
D L Crimmins
J P Atkinson
M Krych-Goldberg
R E Hauhart
V B Subramanian
P2860
P304
P3181
P356
10.1074/JBC.274.44.31160
P407
P577
1999-10-29T00:00:00Z